The Neurology business unit is focused on treatments for stroke, traumatic brain injury, vascular dementia, Alzheimer’s and Parkinson’s disease. We look to continually develop safer and easier to use products in this field and our portfolio encompasses proprietary delivery devices such as pens and pumps as well as drug products.
For example, for patients with advanced Parkinson’s disease, we offer Apomorphine for intermittent off episodes in the form of a single injection pen/cartridge or as a continuous infusion using a mini pump.
The Specialty Injectables business is focused on the development, production and commercialization of complex and value-added injectable formulations that support compliance, convenience and safety for the patients and healthcare professionals. Our R&D team is extensively engaged in the development of a broad portfolio of products in the therapeutic areas of critical care, anesthesia and oncology for global markets.
In addition to our internal development pipeline, we are also interested in broadening our injectable portfolio through in-licensing, acquisition and partnerships.
Combining years of experience and know-how in third party manufacture for global partners we provide high quality sterile production of ampoules, vials and syringes.
Our GMP compliant production site in Jena, Germany, manufactures over 400 different finished medicinal products from more than 50 active ingredients for distribution to more than 50 countries worldwide. As well as a separate production area for filling sterile hormones, the facility also produces sterile implants and handles anesthetics and oil solutions.
We offer a flexible range of fill sizes in high quality ampoules (1ml to 25ml), vials (2ml to 20ml), and either glass or plastic syringes (1ml to 5ml).
For more information, click here.